BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36799463)

  • 1. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.
    Zhang J; Lyu Z; Li B; You Z; Cui N; Li Y; Li Y; Huang B; Chen R; Chen Y; Peng Y; Fang J; Wang Q; Miao Q; Tang R; Gershwin ME; Lian M; Xiao X; Ma X
    Hepatology; 2023 Jul; 78(1):10-25. PubMed ID: 36799463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
    Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
    Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
    Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
    Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
    Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
    Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver Fibrosis, and Angiogenesis in a Model of Cholangitis.
    Owen T; Carpino G; Chen L; Kundu D; Wills P; Ekser B; Onori P; Gaudio E; Alpini G; Francis H; Kennedy L
    Cell Mol Gastroenterol Hepatol; 2023; 16(4):513-540. PubMed ID: 37336290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2
    Meadows V; Kennedy L; Hargrove L; Demieville J; Meng F; Virani S; Reinhart E; Kyritsi K; Invernizzi P; Yang Z; Wu N; Liangpunsakul S; Alpini G; Francis H
    Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165557. PubMed ID: 31521820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2
    Zhou T; Kyritsi K; Wu N; Francis H; Yang Z; Chen L; O'Brien A; Kennedy L; Ceci L; Meadows V; Kusumanchi P; Wu C; Baiocchi L; Skill NJ; Saxena R; Sybenga A; Xie L; Liangpunsakul S; Meng F; Alpini G; Glaser S
    EBioMedicine; 2019 Oct; 48():130-142. PubMed ID: 31522982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2
    Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G
    Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
    Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
    J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockout of the Tachykinin Receptor 1 in the Mdr2
    Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
    Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation.
    Li M; Zhou Y; Zhu H; Xu LM; Ping J
    J Integr Med; 2024 Mar; 22(2):188-198. PubMed ID: 38472011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged administration of a secretin receptor antagonist inhibits biliary senescence and liver fibrosis in Mdr2 -/- mice.
    Wu N; Zhou T; Carpino G; Baiocchi L; Kyritsi K; Kennedy L; Ceci L; Chen L; Wu C; Kundu D; Barupala N; Franchitto A; Onori P; Ekser B; Gaudio E; Francis H; Glaser S; Alpini G
    Hepatology; 2023 Jun; 77(6):1849-1865. PubMed ID: 36799446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis.
    Chen L; Zhou T; White T; O'Brien A; Chakraborty S; Liangpunsakul S; Yang Z; Kennedy L; Saxena R; Wu C; Meng F; Huang Q; Francis H; Alpini G; Glaser S
    Hepatology; 2021 Jun; 73(6):2411-2428. PubMed ID: 32964473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
    Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
    FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans.
    Li X; Liu R; Huang Z; Gurley EC; Wang X; Wang J; He H; Yang H; Lai G; Zhang L; Bajaj JS; White M; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2018 Aug; 68(2):599-615. PubMed ID: 29425397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
    McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
    Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.
    Kyritsi K; Chen L; O'Brien A; Francis H; Hein TW; Venter J; Wu N; Ceci L; Zhou T; Zawieja D; Gashev AA; Meng F; Invernizzi P; Fabris L; Wu C; Skill NJ; Saxena R; Liangpunsakul S; Alpini G; Glaser SS
    Hepatology; 2020 Mar; 71(3):990-1008. PubMed ID: 31344280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
    Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.
    Li X; Liu R; Yang J; Sun L; Zhang L; Jiang Z; Puri P; Gurley EC; Lai G; Tang Y; Huang Z; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2017 Sep; 66(3):869-884. PubMed ID: 28271527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal-7 microRNA.
    McDaniel K; Wu N; Zhou T; Huang L; Sato K; Venter J; Ceci L; Chen D; Ramos-Lorenzo S; Invernizzi P; Bernuzzi F; Wu C; Francis H; Glaser S; Alpini G; Meng F
    Hepatology; 2019 Jun; 69(6):2562-2578. PubMed ID: 30723922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.